The present invention provides a compound having a structure shown in formula (I) or an isomer, pharmaceutically acceptable solvate, or salt thereof. The compound is used as a Bruton's tyrosine kinase inhibitor, and has a higher inhibitory activity against BTK and less adverse effects.
本发明提供了一种具有式(I)所示结构的化合物或其异构体、药学上可接受的溶液或盐。该化合物可用作布鲁顿
酪氨酸激酶
抑制剂,对 BTK 具有较高的抑制活性,且不良反应较少。